home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Onsite Pharmacy Compounding for Your Phase 1 Clinical Study

 
  March 28, 2022  
     
 


xtalks.com, webinar
Tuesday, April 12, 2022 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)


Who Should Attend?

  • QA and QC Managers
  • Operations Managers
  • Regulatory Compliance Managers
  • Chemistry, Manufacturing and Controls (CMC) Managers
  • Consultants

What You Will Learn

  • Updated USP <795>, <797> and <800> Regulations
  • Benefits of onsite pharmacy compounding
  • How to choose a clinical research organization (CRO) with an adequate compounding facility and properly trained staff
  • Tips for making a Phase I study successful
 
 
Organized by: xtalks.com
Invited Speakers:

Speaker

http://Jennifer%20Foster,%20Celerion

Jennifer Foster, Pharm D, RP, Authorized Nuclear Pharmacist, Director of Global Pharmacy Operations, Celerion

Dr. Foster is the Director of Global Pharmacy Operations at Celerion and is located at the Lincoln, Nebraska site. She is responsible for overseeing all three Celerion pharmacies as well as ADME studies from a pharmacy, licensing and total radioactivity reporting perspective. She has worked on over 100 ADME studies with all varieties of formulations and challenges. Dr. Foster graduated from the University of Nebraska Medical Center in 2001 with a Pharm D. In 2016, she completed the Authorized Nuclear Pharmacist program from Purdue University. She joined MDS Pharma Services in August of 2001 in the pharmacy as a Clinical Research Pharmacist. She transitioned to Celerion in 2010.

 
Deadline for Abstracts: na
 
Registration:

https://xtalks.com/webinars/compounded-drugs-onsite-pharmacy-compounding-for-phase-i-clinical-studies/

 

E-mail: shunte@xtalks.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.